Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cartesian Therapeutics (RNAC) Tax Rate (2021 - 2022)

Cartesian Therapeutics (RNAC) has disclosed Tax Rate for 2 consecutive years, with 5.14% as the latest value for Q4 2022.

  • For Q4 2022, Tax Rate fell 625.0% year-over-year to 5.14%; the TTM value through Dec 2022 reached 73.75%, down 64968.0%, while the annual FY2025 figure was 6.59%, 698.0% up from the prior year.
  • Tax Rate hit 5.14% in Q4 2022 for Cartesian Therapeutics, down from 3.91% in the prior quarter.
  • Across five years, Tax Rate topped out at 3.91% in Q3 2022 and bottomed at 766.12% in Q3 2021.